Skip to main content
CG MedTech Co.,Ltd. logo

CG MedTech Co.,Ltd. — Investor Relations & Filings

Ticker · 056090 ISIN · KR7056090004 KO Manufacturing
Open in API
Filings indexed 430 across all filing types
Latest filing 2026-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 056090

About CG MedTech Co.,Ltd.

https://cgmedt.com/

CG MedTech Co., Ltd. is a medical technology company that designs, manufactures, and distributes orthopedic medical devices and surgical implants. The company's product portfolio encompasses solutions for spine, trauma, pain management, sports medicine, and biologics. Key offerings include spinal fixation devices, bioabsorbable alloy implants, and systems for fracture treatment. CG MedTech focuses on regenerative medicine and the development of innovative technologies, such as patient-specific 3D printed implants, to enhance tissue regeneration and improve patient outcomes.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 90% confidence The document is a full "분기보고서" (Quarterly Report) covering the 30th fiscal term for the period 2026.01.01–2026.03.31 filed with the Financial Services Commission and Korea Exchange. It contains substantive sections such as company overview, consolidated subsidiaries, share capital details, financial statements and corporate governance information – typical of a comprehensive interim/quarterly statutory filing rather than a simple announcement. Therefore, it fits the “Interim / Quarterly Report” category. Q1 2026
2026-05-15 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 93% confidence The document is a formal announcement of the results of a regular shareholders’ meeting held on 2026-03-27. It details voting outcomes for each resolution (approval of financial statements, amendments to articles, remuneration limits, etc.) and related attendance/voting rates. This matches the definition for Declaration of Voting Results & Voting Rights Announcements (DVA), as it reports official vote results from an AGM.
2026-03-27 Korean
[기재정정]사업보고서 (2025.12)
Annual Report Classification · 95% confidence The document is a formal 'Correction Report' (정정신고) for an Annual Report (사업보고서) filed with the Korean regulatory authority (DART). It explicitly lists corrections to financial statements (Income Statement, Comprehensive Income Statement, Statement of Changes in Equity, and Cash Flow Statement) for the fiscal years 2023, 2024, and 2025. Since this is a formal amendment to an existing annual report containing substantive financial data, it is classified as an Annual Report (10-K) amendment. FY 2025
2026-03-20 Korean
감사보고서제출
Audit Report / Information Classification · 97% confidence The document is a formal regulatory filing submitted to the KRX (Korea Exchange) titled 'Audit Report Submission' (감사보고서 제출). It contains detailed financial tables including consolidated and separate financial statements, audit opinions, and capital status. While it provides the results of the audit, it is a standardized regulatory disclosure form used to announce the receipt and filing of the audit report rather than the full, multi-page audit document itself. Therefore, it is classified as a Regulatory Filing (RNS). FY 2025
2026-03-19 Korean
사업보고서 (2025.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for the company '주식회사 시지메드텍' (CG MedTech Co., Ltd.) for the fiscal year ending December 31, 2025. It includes the independent auditor's report, financial statements (Statement of Financial Position, Income Statement, Comprehensive Income Statement, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements. This is a comprehensive financial audit document, not an annual report (10-K) which typically includes management discussion and analysis (MD&A) and broader business descriptions, nor is it a short announcement. Therefore, it is classified as an Audit Report. FY 2025
2026-03-19 Korean
[기재정정]주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for CG MedTech. It contains the meeting agenda, details on voting procedures (including electronic voting), board activity reports, and financial statements for the 29th fiscal year. This document is a formal proxy statement/notice sent to shareholders to inform them of the upcoming meeting and solicit their votes, which aligns with the definition of a Proxy Solicitation & Information Statement.
2026-03-13 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.